20 Jan 2022 , 03:30 PM
Suven Pharma Ltd. announced that Dr. Chandrasekhar Srivari has resigned from the position of the Non-executive Independent Director of the Company with effective from January 19, 2022 due to new appointment as Secretary, Department of Science and Technology, Govt. of India, New Delhi.
Dr. Srivari Chandrasekhar, has completed all his primary and higher education in Hyderabad and Joined CSIR, IICT for a Ph. D Programme. After completing his Ph. D (1991) with the then director Dr. A. V. Rama Rao, he moved to USA to pursue his post-doctoral position with Prof. J. R. Falck (1991-94).
He joined as Scientist C in 1994 in Council of Scientific and Industrial Research — Indian Institute of Chemical Technology (“CSIR-IICT”), and grew upto the level of director in 2015.
The company’s share is currently trading at Rs 535.35 against its previous closing price of Rs 549.95, down by Rs 14.60 (2.65%).
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
